Tandem Diabetes Care Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +46.5% | +15.6% | +27.7% | +70.9% | +97.0% | +37.7% | +40.9% | +14.0% | -6.7% | +25.7% | +7.9% | |
| – | +34.2% | +31.1% | +4.7% | +48.1% | +78.7% | +41.8% | +37.0% | +18.9% | -2.1% | +18.6% | +7.4% | |
| – | +74.3% | -11.2% | +86.9% | +103.7% | +116.2% | +34.1% | +44.4% | +9.8% | -11.0% | +33.1% | +8.4% | |
| – | +7.4% | +10.9% | +9.8% | +41.5% | +54.6% | +40.7% | +44.8% | +84.8% | +46.0% | -19.9% | -12.1% | |
| – | +4.7% | +5.4% | +4.3% | +21.8% | +57.5% | +23.6% | +27.6% | +28.4% | +5.0% | +10.6% | +14.2% | |
| – | +5.1% | +6.3% | +5.3% | +25.6% | +56.9% | +27.3% | +31.7% | +43.1% | +18.8% | -2.0% | +3.4% | |
| – | – | – | – | – | – | – | – | -509.9% | – | – | – | |
| – | -4.1% | +52.6% | +98.7% | -33.1% | -99.0% | +15,480.8% | -50.3% | +2.8% | +59.2% | -25.0% | +6.6% | |
| – | – | – | – | – | – | – | – | -683.9% | – | – | – | |
| – | -85.9% | -250.0% | – | +537.5% | +192.2% | -1,375.2% | – | +420.0% | +35.3% | +76.3% | +6.8% | |
| – | – | – | – | – | – | – | – | -707.7% | – | – | – | |
| – | – | – | – | – | – | – | +1,265.6% | -317.9% | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.